Sleep Apnea Screening: What STOP-BANG Can and Cannot Tell You

Physician Article Dr. Brian Harris
Sleep Apnea Screening: What STOP-BANG Can and Cannot Tell You
Why this matters

A screening score can tell you who deserves a closer look. It cannot tell you, by itself, what is happening in your airway at 2:13 a.m. STOP-BANG is a powerful tool for predicting risk, but it’s a triage tool, not a verdict.

In plain language

Doctors use a simple checklist called STOP-BANG to figure out if you might have sleep apnea. It stands for:

  • Snoring (loud enough to be heard through a door?)
  • Tired (sleepy during the day?)
  • Observed (has anyone seen you stop breathing?)
  • Pressure (high blood pressure?)
  • BMI (over 35?)
  • Age (over 50?)
  • Neck (large neck size?)
  • Gender (male?)

The more "yes" answers you have, the higher your risk. It’s great for deciding who needs a sleep study, but it doesn't *diagnose* you. You could have a high score and not have apnea, or a low score and still have a significant problem.

Clinical deep dive

The STOP-BANG questionnaire is a validated screening instrument used for risk stratification of OSA, particularly in preoperative and primary care settings.

Sensitivity and Specificity

STOP-BANG has high sensitivity (it’s very good at catching potential cases) but lower specificity (it may flag people who don't actually have clinically significant disease).
  • A score of 0–2 indicates low risk.
  • A score of 3–4 indicates intermediate risk.
  • A score of 5–8 indicates high risk.

Clinical Limitations

STOP-BANG is an "anatomical and demographic" snapshot. It does not account for: 1. REM-Related OSA: Some patients have severe apnea only during REM sleep, which STOP-BANG may miss if they are thin or younger. 2. Central Sleep Apnea: It is designed for *obstructive* pathology and may under-perform in patients with heart failure or opioid-induced central apnea. 3. Phenotypic Variation: It may under-estimate risk in post-menopausal women, who often present with "insomnia-like" symptoms rather than loud snoring.

The clinician's role is to use STOP-BANG to justify further diagnostic testing (HSAT or PSG), not to determine treatment.